Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer

Not Applicable

Withdrawn

Conditions: Breast Cancer

Interventions: Drug: Ganetespib
Drug: Paclitaxel
Drug: Doxorubicin
Drug: Cyclophosphamide

First Posted Date: 2015-12-22

Last Posted Date: 2016-05-30

Lead Sponsor: University of Chicago

Registration Number: NCT02637375

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

Phase 4

Completed

Conditions: Neuromuscular Blockade
Postoperative Complications

Interventions: Drug: Cisatracurium
Drug: Succinylcholine

First Posted Date: 2015-12-21

Last Posted Date: 2018-07-17

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT02635542

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease
Asthma

Interventions: Behavioral: Video Module Education (VME)
Behavioral: Teach-To-Goal (TTG)

First Posted Date: 2015-11-20

Last Posted Date: 2018-05-24

Lead Sponsor: University of Chicago

Target Recruit Count: 142

Registration Number: NCT02611531

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Phase 1

Active, not recruiting

Conditions: Solid Tumor

Interventions: Radiation: Stereotactic body radiotherapy (SBRT)
Drug: Pembrolizumab

First Posted Date: 2015-11-18

Last Posted Date: 2024-05-13

Lead Sponsor: University of Chicago

Target Recruit Count: 117

Registration Number: NCT02608385

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Phase 1

Active, not recruiting

Conditions: Cerebral Cavernous Malformation

Interventions: Other: Placebo
Drug: Atorvastatin

First Posted Date: 2015-11-11

Last Posted Date: 2024-11-07

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT02603328

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Ecological Momentary Assessment of Eating Behavior in Overweight Youth

Completed

Conditions: Obesity

First Posted Date: 2015-10-23

Last Posted Date: 2024-05-07

Lead Sponsor: University of Chicago

Target Recruit Count: 44

Registration Number: NCT02585518

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine
Drug: Mitoxantrone Hydrochloride
Drug: Selinexor

First Posted Date: 2015-10-09

Last Posted Date: 2020-04-08

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT02573363

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Phase 1

Withdrawn

Conditions: Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer

Interventions: Biological: Cetuximab
Drug: Fluorouracil
Drug: Irinotecan Hydrochloride
Drug: Leucovorin Calcium

First Posted Date: 2015-10-09

Last Posted Date: 2016-12-09

Lead Sponsor: University of Chicago

Registration Number: NCT02573220

Locations: 🇮🇹
Centro di Riferimento Oncologico, Aviano, Italy

A Study to Determine if Caffeine Accelerates Emergence From Anesthesia

Phase 4

Completed

Conditions: Anesthesia

Interventions: Drug: Placebo Control
Drug: Caffeine

First Posted Date: 2015-10-05

Last Posted Date: 2018-08-16

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT02567968

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Electrical Nerve Stimulation of the Ulnar Nerve

Not Applicable

Withdrawn

Conditions: Cubital Tunnel Syndrome

Interventions: Device: Ulnar Nerve Stimulation

First Posted Date: 2015-10-02

Last Posted Date: 2017-04-05

Lead Sponsor: University of Chicago

Registration Number: NCT02566616

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy